EspeRare is a nonprofit organisation established in Switzerland in 2013. It is recognised to be operating in the public's interest.
A world in which patient engagement, good science, pharmaceutical excellence and health authorities come together to address the medical needs of rare diseases patients, ultimately alleviating the healthcare burden of their conditions.
In collaboration with patient groups and other key stakeholders, we uncover the potential of existing molecules to address severe therapeutic unmet needs in rare diseases. Through the identification and validation of these therapeutic opportunities we address the translational gap in rare disease drug development. Thus, giving better chances for existing drug to reach these patients.
“It is time to renovate and accelerate the discovery and development of drugs for rare diseases. EspeRare is an essential player in the innovative, collaborative system that will be created to make a difference in this world.”
EspeRare President, CEO of Genetic Alliance & Board Member of IRDiRC
As a private non-for-profit organisation, we strive to uncover the potential of existing molecules to address severe therapeutic unmet needs in rare diseases, thus giving better chances to existing drugs to reach these underserved patients.